Matthew Blischak
Directeur Général chez FINCH THERAPEUTICS GROUP, INC.
Fortune : - $ au 30/04/2024
Postes actifs de Matthew Blischak
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Directeur Général | 16/05/2023 | - |
| President | 16/05/2023 | - | |
| Secrétaire Général | 16/05/2023 | - |
Historique de carrière de Matthew Blischak
Anciens postes connus de Matthew Blischak
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/05/2018 | 01/04/2023 |
Formation de Matthew Blischak
| Case Western Reserve University | Undergraduate Degree |
| American University Washington College of Law | Graduate Degree |
| The Johns Hopkins University | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Graduate Degree | 2 |
| Chief Executive Officer | 1 |
| President | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Health Services |
| Entreprise privées | 1 |
|---|---|
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
- Bourse
- Insiders
- Matthew Blischak
- Expérience